Rice Partnership, LLC Biogen Inc. Transaction History

Rice Partnership, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 25, 2019	SELL	$219.29 - $241.72 $277,182 - $305,534	-1,264 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$216.71 - $338.96 $32,289 - $50,505	149 Added 13.36%	1,264 $299,000
Q4 2018 Jan 22, 2019	BUY	$278.5 - $352.75 $35,091 - $44,446	126 Added 12.74%	1,115 $336,000
Q3 2018 Nov 15, 2018	BUY	$293.51 - $383.83 $290,281 - $379,607	989 New	989 $349,000

998

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Rice Partnership, LLC, based on Form 13F filings with the SEC.

Stay updated on Rice Partnership, LLC with notifications on news.